London, UK. 21st Nov, 2017. A press briefing by Guido Rasi, Executive Director of EMA and Noel Whation Deputy Executive Director of EMA European Medecines Agency who addressed the media after the anouncement to relocate to Amsterdam was taken by the General Affairs Council of 27 EU member states which was influenced by Brexit and the decision of the United Kingdom to leave the European Union. Credit: amer ghazzal/Alamy Live News

- Image ID: KJ26DN
London, UK. 21st Nov, 2017. A press briefing by Guido Rasi, Executive Director of EMA and Noel Whation Deputy Executive Stock Photo
Enlarge
https://www.alamy.com/licenses-and-pricing/?v=1 https://www.alamy.com/stock-image-london-uk-21st-nov-2017-a-press-briefing-by-guido-rasi-executive-director-166006113.html
London, UK. 21st Nov, 2017. A press briefing by Guido Rasi, Executive Director of EMA and Noel Whation Deputy Executive Director of EMA European Medecines Agency who addressed the media after the anouncement to relocate to Amsterdam was taken by the General Affairs Council of 27 EU member states which was influenced by Brexit and the decision of the United Kingdom to leave the European Union. Credit: amer ghazzal/Alamy Live News
amer ghazzal / Alamy Stock Photo
Image ID: KJ26DN
A press briefing by Guido Rasi ,Executive Director of EMA and Noel Whation Deputy Executive Director of EMA European Medecines Agency who addressed the media after the anouncement to relocate to Amsterdam was taken by the General Affairs Council of 27 EU member states which was influenced by Brexit and the decision of the United Kingdom to leave the European Union. The (EMA) European Medecines Agency which helps national authorities authorise the sale of drugs across the EU's single market of some 500 million people has has been based at Canary Wharf in east London since it was founded in 1995 and has about 900 staff
Location: London, United Kingdom